These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2381273)

  • 41. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine.
    Paul BD; McWhorter LK; Smith ML
    J Mass Spectrom; 1999 Jun; 34(6):651-60. PubMed ID: 10394630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robotic method for the analysis of cocaine and benzoylecgonine in urine.
    Taylor RW; Le SD
    J Anal Toxicol; 1991; 15(5):276-8. PubMed ID: 1960981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of benzoylecgonine in urine from drug abusers using ion pair high performance liquid chromatography.
    Svensson JO
    J Anal Toxicol; 1986; 10(3):122-4. PubMed ID: 3724072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLC analysis of urine for benzoylecgonine and norpropoxyphene.
    Budd RD; Mathis DF; Yang FC
    Clin Toxicol; 1980 Mar; 16(1):1-5. PubMed ID: 7389277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.
    Mulé SJ; Jukofsky D; Kogan M; De Pace A; Verebey K
    Clin Chem; 1977 May; 23(5):796-801. PubMed ID: 322891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of benzoylecgonine and cocaine in urine, separation of various cocaine metabolites using reversed-phase high-performance liquid chromatography.
    Jatlow PI; Van Dyke C; Barash P; Byck R
    J Chromatogr; 1978 May; 152(1):115-21. PubMed ID: 649742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergency department evaluation of a rapid assay for detection of cocaine metabolites in urine specimens.
    Belfer RA; Klein BL; Boenning DA; Soldin SJ
    Pediatr Emerg Care; 1996 Apr; 12(2):113-5. PubMed ID: 8859922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection and confirmation of cocaine use by chromatographic analysis for methylecgonine in urine.
    Clark DR; Hajar TM
    Clin Chem; 1987 Jan; 33(1):118-9. PubMed ID: 3542285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody-mediated interference of a homogeneous immunoassay.
    Critchfield GC; Wilkins DG; Loughmiller DL; Davis BW; Rollins DE
    J Anal Toxicol; 1993; 17(2):69-72. PubMed ID: 8492569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolonged detection period for cocaine and metabolite.
    Weddington WW
    J Clin Psychiatry; 1990 Aug; 51(8):347. PubMed ID: 2380162
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of cocaine as an anesthetic in lacrimal surgery.
    Patrinely JR; Cruz OA; Reyna GS; King JW
    J Anal Toxicol; 1994; 18(1):54-6. PubMed ID: 8127087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of validity of the KDI Quik Test Drug Screen for detection of benzoylecgonine in urine.
    Cone EJ; Menchen SL
    J Anal Toxicol; 1987; 11(6):276-7. PubMed ID: 3431098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of common drug screen tests.
    Schwartz JG; Zollars PR; Okorodudu AO; Carnahan JJ; Wallace JE; Briggs JE
    Am J Emerg Med; 1991 Mar; 9(2):166-70. PubMed ID: 1994947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Routine detection of benzoylecgonine in urine at a sensitivity of 35 ng/mL by a combination of EMIT and gas chromatography/mass spectrometry.
    Joern WA
    J Anal Toxicol; 1987; 11(3):110-2. PubMed ID: 3298855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary excretion of immunologically reactive metabolite(s) after intranasal administration of cocaine, as followed by enzyme immunoassay.
    Van Dyke C; Byck R; Barash PG; Jatlow P
    Clin Chem; 1977 Feb; 23(2 PT. 1):241-4. PubMed ID: 318942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OnLine kinetic microparticle immunoassay of cannabinoids, morphine, and benzoylecgonine in serum.
    Moody DE; Medina AM
    Clin Chem; 1995 Nov; 41(11):1664-5. PubMed ID: 7586561
    [No Abstract]   [Full Text] [Related]  

  • 58. Detection of benzoylecgonine in human urine.
    Mueller MA; Adams SM; Lewand DL; Wang RI
    J Chromatogr; 1977 Nov; 144(1):101-7. PubMed ID: 914955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the cocaine metabolite in the urine of patients and physicians during clinical use.
    Bruns AD; Zieske LA; Jacobs AJ
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):722-6. PubMed ID: 7991250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thin-layer chromatographic analysis of cocaine and benzoylecgonine in urine.
    Wallace JE; Hamilton HE; Schwertner H; King DE; McNay JL; Blum K
    J Chromatogr; 1975 Nov; 114(2):433-41. PubMed ID: 1202048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.